YorkBridge Wealth Partners’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-131
| Closed | -$9K | – | 448 |
|
|
2019
Q2 | $9K | Sell |
131
-23
| -15% | -$1.58K | ﹤0.01% | 584 |
|
|
2019
Q1 | $12K | Sell |
154
-45
| -23% | -$3.51K | 0.01% | 552 |
|
|
2018
Q4 | $17K | Hold |
199
| – | – | 0.01% | 495 |
|
|
2018
Q3 | $34K | Sell |
199
-30
| -13% | -$5.13K | 0.02% | 401 |
|
|
2018
Q2 | $30K | Sell |
229
-72
| -24% | -$9.43K | 0.01% | 433 |
|
|
2018
Q1 | $31K | Buy |
301
+35
| +13% | +$3.61K | 0.01% | 425 |
|
|
2017
Q4 | $25K | Sell |
266
-3
| -1% | -$282 | 0.01% | 461 |
|
|
2017
Q3 | $23K | Buy |
269
+24
| +10% | +$2.05K | 0.01% | 487 |
|
|
2017
Q2 | $18K | Hold |
245
| – | – | 0.01% | 536 |
|
|
2017
Q1 | $17K | Buy |
245
+104
| +74% | +$7.22K | 0.01% | 542 |
|
|
2016
Q4 | $9K | Buy |
+141
| New | +$9K | 0.01% | 609 |
|